7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication
Key facts
- Who runs it
- Alexandria University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 326 people enrolled
- Started
- 30 Jun 2024
- Ended
- 1 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vonoprazan
- Amoxicillin
- Clarithromycin
- Record updated
- 11 February 2025
Who can take part
- Age
- 10 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Participants in the age group (10-18 years), both genders, referred with dyspeptic complaints such as heartburn, dyspepsia, nausea, and epigastric pain who are positive for H. Pylori infection by a standardized diagnostic test
- Pediatric patients with a clinical, laboratory, and endoscopic diagnosis of H.P.-positive gastritis and the other conditions necessary for H.P. eradication, according to the Maastricht V consensus report
Who cannot take part
- previous attempts to eradicate H.P
- allergy to any of the drugs used in the study
- Children with the diagnosis of any condition that might affect the absorption of drugs such as celiac disease or Crohn's disease
- hepatic impairment or kidney failure
- symptoms suggestive of functional disorders
- receipt of antibiotics, PPIs, bismuth, H2 antagonists or probiotics within 4 weeks of the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study aims to test the efficacy of 7 days vs. 14 days of Vonoprazan-triple therapy in the eradication of Helicobacter Pylori infection in adolescents and young children.
The 2 groups in the trial
- 14-days Vonoprazan-based triple therapyExisting treatment, for comparison
Vonoprazan tablets 20 mg twice daily plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\]. The triple combination will be given for 14 days .
Treatment: Vonoprazan, Amoxicillin, and Clarithromycin
- 7-days Vonoprazan-based triple therapyTreatment being tested
Vonoprazan tablets 20 mg twice daily plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\]. The triple combination will be given for 7 days.
Treatment: Vonoprazan, Amoxicillin, and Clarithromycin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- 7-day Versus 14-day Vonoprazan-based Triple Therapy for Eradication of H. Pylori in Adolescents: A Randomized Controlled Trial
- Record updated
- 11 February 2025